Type I vs Type IV Latex Allergy and Skin-Contact Labeling Reality
Not medical advice. This article is literacy: names for reaction classes, typical timing patterns, and what labels do or do not mean. It is not diagnosis, treatment, emergency protocol, or a product “safe to wear” certificate. Seek a qualified clinician for symptoms. Do not self-diagnose, self-treat, or treat any sheet, bottle, or garment as medically cleared.
Executive summary
“Latex allergy” covers three different patterns. One is an immediate reaction to proteins in natural rubber latex (NRL). Another is a delayed contact reaction to cure chemicals (accelerators and related additives). A third is irritant dermatitis, which is not that immune allergy. Collapsing them into one bucket leads to the wrong avoidance and to false safety from “hypoallergenic,” “FDA,” or “food-contact” talk.
Use this before first skin-contact wear, when choosing a liquid-latex bottle, when a seller says “hypoallergenic” or “FDA,” or when a rash appears after wearing. Medical devices that contain natural rubber latex must carry a specific caution and must not say “hypoallergenic” on that NRL device. Fashion sheet, craft liquid, and catsuits typically sit outside that rule. Food-contact rubber tables list accelerators for food; they are not dermal wear clearance.
Three reaction classes (literacy only)
Not medical advice. Timing and class names below are literacy, not a self-test. Overlapping rashes happen. Do not diagnose from a clock.
NIOSH’s 1997 Alert on NRL gloves and other NRL products separates three patterns:
| Class (literacy name) | What the source is talking about | Typical timing pattern (not diagnosis) |
|---|---|---|
| Irritant contact dermatitis | Skin irritation from gloves, washing, powder; not true allergy | Often during or soon after exposure; not an IgE “latex allergy” label |
| Delayed / Type IV-like (allergic contact dermatitis) | Reaction to processing chemicals, not to the rubber proteins | Usually 24–48 h after contact in NIOSH’s wording |
| Immediate / Type I (NRL protein) | Immune reaction to NRL proteins; minutes to hours in previously sensitized people | Minutes to hours; can include systemic immediate reactions |
NIOSH: NRL proteins can cause allergic reactions; processing chemicals added during manufacturing can cause skin rashes; products called “latex” that are synthetics do not release those NRL proteins. OSHA’s hospital eTool uses the same three-way split and warns: do not assume hypoallergenic or powderless gloves are non-latex.
Clinical reviews use the same split: Hevea proteins → Type I; processing chemicals / antioxidants → Type IV. Public literacy from AAAAI: delayed-type contact dermatitis often 12–36 h, usually from added chemicals; immediate reactions in previously sensitized people; anaphylaxis named as a severe immediate pattern. AAAAI’s glossary: immune overreaction to proteins in NRL; synthetic “latex” paints not shown to pose that protein hazard to latex-sensitive individuals.
Do not copy treatment or epinephrine instructions from those pages into this article. Not medical advice.
For storage and oils that can irritate skin or film, see Aging, Storage and Care — that article does not diagnose reactions either.
Timing literacy (not diagnosis)
- Immediate / protein (Type I literacy): minutes to hours after contact in NIOSH’s triad; AAAAI: immediate reactions in previously sensitized people.
- Delayed / chemical (Type IV literacy): NIOSH: allergic contact dermatitis from chemicals, usually 24–48 h. AAAAI public page: delayed-type contact dermatitis 12–36 h, usually added chemicals. Those windows overlap in the real world. A clock is not a lab test.
- Irritant: NIOSH lists irritant contact dermatitis as not true allergy. Ammonia odor on liquid-latex concentrate can cause human discomfort (especially above 0.3% ammonia in the Practical Guide’s wording) and is not Type I or Type IV in that composition discussion.
If a wearer or maker notices a new rash, hives, breathing trouble, or swelling after latex contact, stop wearing / stop compounding that article and seek clinical care. That sentence is a literacy stop-rule, not a treatment protocol.
What is in the film (categories, not personal risk scores)
Names of families, not a prediction of your reaction.
Proteins (NRL feedstock)
Fresh NRL is not “just rubber.” Table 2.1: rubber 30–35%; proteins 1–1.5%, plus resins, carbohydrates, minerals, water. The rubber particle surface is covered by a protein-lipid envelope; lutoid membranes are protein.
What is natural rubber latex (NRL)?
Natural rubber latex (NRL) is the milky fluid tapped from Hevea rubber trees. It is a water suspension of rubber particles plus proteins, sugars, and other plant material. “Latex allergy” in the protein sense means reacting to those Hevea proteins — not to synthetic paints or adhesives that happen to be called “latex.”
Sheet-based work and liquid latex work both start from Hevea NRL if the product is natural rubber. Glove protein QC is a different lineage from fashion sheet — see the agent deep dive on protein methods.
“Latex allergy” in the protein sense is an immune overreaction to proteins in NRL. ASTM D6499’s significance statement (method class): Type I from HNRL proteins vs Type IV from chemical additives.
Accelerator families (compounding)
Organic accelerators plus zinc oxide enable fast latex-film cure; many are active below 100 °C. Handbook Table 1 types include thiuram, dithiocarbamate, xanthate, thiazole (including sulfenamide), thiourea, guanidine. Dithiocarbamates are the fastest and most used for latex; thiazoles and thiurams are too slow alone and are used as secondaries.
What are accelerators?
Accelerators are small organic chemicals added to rubber compounds so vulcanization (curing) happens faster at lower temperatures. Common families include dithiocarbamates, thiurams, and thiazoles (such as mercaptobenzothiazole). Type IV contact dermatitis in occupational settings often traces to these cure chemicals, not to the rubber proteins themselves.
Clinical Type IV lists match those families, not a fashion SKU: carbamates, thiuram mix, 2-mercaptobenzothiazole (2-MBT), 1,3-diphenylguanidine among common patch positives; Type IV ACD from thiurams, carbamates, mercaptobenzothiazoles.
With more vulcanized rubber contacting skin, dermatitis from certain vulcanization accelerators (and antioxidants) has drawn increasing concern; a localized reaction can generalize so the whole body surface becomes sensitized. Gloves and condoms are named as the latex-derived products of greatest concern because they are in intimate skin contact during use — still an industrial/clinical frame, not fashion catsuit epidemiology.
Liquid latex work concentrate note: a popular low-ammonia (LATZ) system is 0.2% ammonia + 0.0125% each TMTD and ZnO + 0.05% lauric acid. Low-ammonia NR with a thiuram sulphide or dithiocarbamate secondary preservative is flagged in industrial literature when designing goods for human contact — industrial concentrate chemistry, not a sheet assay.
SDS class ≠ diagnosis. A representative zinc bis(diethyldithiocarbamate) (ZDEC) laboratory SDS: GHS Skin Sens. 1; H317 “May cause an allergic skin reaction.” That is the neat chemical’s hazard class, not a diagnosis of a worn garment.
Loadings, trade-name maps, and glove compounding examples live in Deep dive: Accelerator chemical families. They are not craft recipes.
What labels mean (devices vs fashion)
21 CFR 801.437 is medical-device NRL labeling. Scope in the rule: devices that contain natural rubber latex contacting humans. Proteins are the hazard named in (a). Required user labeling includes a bold caution: this product contains natural rubber latex which may cause allergic reactions. (h) the labeling shall not contain the term “hypoallergenic.” Noncompliance is misbranding under the rule’s (j).
The 1997 final rule explains the caution on medical devices/packaging containing NRL or dry natural rubber contacting humans, and why hypoallergenicity claims were removed: Draize-type tests were inappropriate for protein sensitivity. OSHA’s eTool cites 801.437 in the hospital-glove setting.
If a catsuit, sheet roll, or craft bottle lacks a device-style NRL caution, that absence is not evidence that the product is protein-free or accelerator-free. If a fashion listing says “hypoallergenic,” that word is not the 801.437 device prohibition being satisfied. Fashion is typically outside that rule. The word is not a Type I / Type IV clearance.
Food-contact FDA ≠ wear certification
21 CFR 177.2600 is Rubber articles intended for repeated use in producing, packing, or holding food. Accelerator listings and a total cap (not to exceed 1.5% by weight of rubber product) live under that food-contact rule, with extractive limits and a cleanse-before-first-food-use note. Vanderbilt reprints the same food-contact identity map (thiazoles, dithiocarbamates, thiurams, guanidines as accelerators). Antidegradants appear under a separate food-contact cap. None of those rows is a dermal wear or allergy certificate.
Do not treat a food-contact table row, an “FDA” badge on a listing, or “skin-safe” marketing as dermatological approval.
Sheet-based work vs liquid latex work: leach and powder
Advice differs here. Do not apply glove-leach language to a bought roll, or fashion-sheet silence to a dipped former line.
Liquid latex work — dipped / coagulant goods
For latex-dipped products intended to contact the human body, the vulcanizing system should be designed to minimize N-nitrosamines and N-nitrosatable amines. That is a liquid latex work industrial formulation principle for gloves, condoms, and similar dipped lines — not a home cast-and-wear SOP.
A warm-water leach tank is required for coagulant-dipped products; circulate; do not reuse leach water unless leached materials are removed. The stated purpose of warm-water leach is to extract coagulant from the wet gelled latex film; more thorough leach → higher cured film properties, better aging, less discoloration. That leach discussion does not say it reduces Type I protein.
Protein language is on the Practical Guide glove line: pre-cure leach (~80 °C) “removes the excess chemicals.” Post-leach: leach again in hot water to “remove the water-soluble protein and chemicals” so residual protein of gloves is kept to a minimum. Glove performance lists include protein content and antigenic protein content. A named functional defect: increased protein levels from insufficient leaching or high protein latex.
NIOSH: powder binds proteins (Type I amplifier in the glove/occupational story). FDA banned powdered surgeon’s / patient-exam gloves and absorbable lubricating powder; NRL allergen on powder is among the named risks. Non-powdered NRL gloves still use §801.437. This is not a fashion-garment powder ban.
A maker who dips (liquid latex work) inherits the idea that leach extracts water-soluble stuff from a wet gel. Copying tank temperatures, dwell, or “this dip is medical-glove protein grade” without a measured method is not supported.
Sheet-based work — commercial sheet / finished fashion garments
Industrial leach texts are glove/dipped. ISO 12243 assays water-extractable protein in NR medical gloves; the standard does not address safety or labelling; extraction for non-glove NR articles is not validated. You cannot convert a glove protein number into garment safe/unsafe.
Both paths (same advice): Type I vs Type IV literacy, no DIY patch test, food-contact ≠ wear cert, 801.437 is a device rule, stop-and-seek-care if symptoms.
For glue and seam work after a reaction, see Adhesives and Seam Integrity.
Buyer / maker checklist (questions, not self-tests)
Not medical advice. These are questions to a seller or to your own notes, not a home challenge test. Do not DIY patch-test a garment or bottle on skin to “see if you’re allergic.”
| Ask | Why it matters | What silence means |
|---|---|---|
| Is this natural rubber latex (Hevea NRL), or a synthetic called “latex”? | NRL proteins are the Type I story; synthetics named “latex” do not release those proteins in NIOSH’s wording | If unnamed, assume you cannot rule NRL in or out |
| Does labeling include a device-style NRL caution (801.437)? | Required for in-scope devices | Absence on fashion goods ≠ protein-free |
| Does the listing say hypoallergenic? | Banned on NR devices under 801.437(h); on fashion it is unregulated marketing | Not a Type I/IV clearance |
| Are accelerator families named (dithiocarbamate / thiuram / thiazole) or is an SDS available? | Type IV literacy is chemical families; SDS H317 is class, not diagnosis | Typical fashion silence; do not invent disclosure law |
| Any protein method cited (D5712 total extractable protein vs D6499 antigenic protein)? | Method classes; D6499 antigenic ≠ proven allergenic correlation | Fashion numbers rarely cited |
| Liquid latex work: is this dipped/leached glove-lineage stock or a craft bottle? | Post-leach protein language is gloves | Do not assume glove QC |
| Sheet-based work: any leach / protein / accelerator certificate for this sheet lot? | Fashion sheet dataset thin | Buy as unlabeled film, not as a medical device |
| “FDA” or food-contact on the card? | 177.2600 is food, not skin | Not a wear cert |
Makers cannot test wearers. Document what you actually know (NRL vs synthetic, SDS if you have one). You cannot honestly certify “safe for Type I” or “safe for Type IV” from this literature pack.
When to stop and seek care
Not medical advice. No treatment steps.
Stop wearing or handling the article and seek a qualified clinician if you notice a new rash, hives, swelling, breathing difficulty, or any reaction you worry about after latex contact. Immediate-pattern and delayed-pattern literacy is above; it is not a rule-out. Do not wait for a forum to name Type I vs Type IV. Do not “challenge” the garment to confirm. Do not treat chlorination, shine, or a different oil as a cure.
This review does not tell you which drug, which specialist algorithm, or which “safe” SKU to switch to.
Deep dives (optional)
Skipping these does not break the main path. Still not medical advice.
Deep dive: Accelerator chemical families (handbook map)
phr = parts per hundred rubber. Tables are handbook examples, not craft recipes.
Vanderbilt Table 1 types: thiuram (METHYL TUADS), dithiocarbamate (BUTYL ZIMATE), xanthate (PROPYL ZITHATE), thiazole including sulfenamide (mercapto CAPTAX / ZETAX; sulfenamide MORFAX), thiourea (THIATE U), guanidine.
Dithiocarbamates fastest and most used; thiazoles too slow alone (secondary with dithiocarbamates); thiurams too slow alone (boost with dithiocarbamates/thioureas; low/no free sulfur).
Wilson patch series (clinic accelerators, not garment assay):
| Accelerator tested (neat, dilute) | Positive reactions (of 42 clinic patients) |
|---|---|
| Dipentamethylenethiuram disulphide | 30 |
| Tetramethylthiuram disulphide (TMTD class) | 20 |
| 2-Mercaptobenzthiazole (MBT) | 15 |
| Zinc diethyldithiocarbamate (ZDEC class) | 2 |
Surgeon-glove example (handbook, not craft recipe)
| Ingredient (Table 4.4 excerpt) | phr (handbook) |
|---|---|
| 50% ZDEC/ZDBC | 0.50–0.85 |
| 50% ZMBT | 0.25–0.45 |
21 CFR 177.2600 identity + cap. Accelerators total not to exceed 1.5% by weight of rubber product. Food-contact, not dermal clearance.
Deep dive: Protein measurement method classes
| Method | What it reports | What it does not do |
|---|---|---|
| ASTM D5712 (modified Lowry) | Total aqueous extractable protein (µg/dm² class) | Not allergen-specific; total protein ≠ clinical potency |
| ASTM D6499 | Antigenic (not necessarily allergenic) Hevea protein | Not a pass/fail “safe garment”; allergenic correlation not fully established |
| ISO 12243:2003 | Water-extractable protein in NR medical gloves | Does not address safety or labelling; non-glove extraction not validated |
Practical Guide Category 4 prose: less than 200 µg total protein per gram dry weight of latex for low-protein concentrate.
Glove process: post-leach to minimize residual protein; defect = increased protein from insufficient leaching / high-protein latex.
Deep dive: Device labeling and powder history
801.437 in one place. (a) latex proteins; (b) devices with NR contacting humans; (d) bold caution that the product contains natural rubber latex which may cause allergic reactions; (h) shall not contain “hypoallergenic”; (j) misbranded if noncompliant.
1997 FR rationale. Caution on medical devices/packaging containing NRL/dry NR contacting humans; hypoallergenicity claims removed because Draize-type tests were inappropriate for protein sensitivity.
2016 powder ban. Bans powdered surgeon’s / patient exam gloves and absorbable lubricating powder; NRL allergen on powder among risks; non-powdered NRL gloves still labeled under §801.437. NIOSH: powder binds proteins.